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Abstract 
MAPKs are involved in acetaminophen (APAP)-hepatotoxicity, but the regulatory 
mechanism remains unknown. Here, we explored the role of Spred-2 that negatively 
regulates Ras/ERK pathway in APAP-hepatotoxicity. Spred-2 knockout (KO) mice 
demonstrated exacerbated liver injury, an event that was associated with increased 
numbers of CD4+T, CD8+T and NK cells in the liver compared to the control. Levels of 
CXCL9/CXCL10 that attracts and activates these cells were enhanced in Spred-2 
KO-liver. Kupffer cells isolated from Spred-2 KO mice after APAP challenge expressed 
higher levels of CXCL9/CXCL10 than those from the control. Upon stimulation with 
APAP and IFNγ, naïve Kupffer cells from Spred-2 KO mice expressed higher levels of 
CXCL9/CXCL10. NK cell-depletion attenuated APAP-hepatotoxicity with lowered 
hepatic IFNγ and decreased numbers of not only NK cells but also CD4+T and CD8+T 
cells in the liver. These results suggest that Spred-2 negatively regulates 
APAP-hepatotoxicity under the control of Kupffer cells and NK cells. 
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1. Introduction 
 
Acetaminophen (APAP) is widely used as a safety analgesic and antipyretic agent. 
Although considered safe at therapeutic doses, an accidental or intentional APAP 
overdose often causes acute liver failure with high morbidity and mortality [1]. The 
hepatotoxicity is mediated by a toxic metabolite N-acetyl-p-benzoquinone imine 
(NAPQI). Normally, NAPQI is detoxified by glutathione in the liver. In overdose 
glutathione is exhausted, thereby NAPQI covalently binds to cellular proteins and 
nonprotein thiols, initiating hepatocellular death due to oxidative stress. Hepatocyte 
injury in turn induces expressions of inflammatory molecules including cytokines and 
chemokines, resulting in an extensive severe liver damage [2]. 
 There is a great interest in studying the cellular processes and signaling 
pathways during APAP-induced liver injury. We have found in a murine model of 
APAP-hepatotoxicity that suppressor of cytokine signaling (SOCS)3 in T cells negatively 
regulates hepato-damaging IFNγsignaling by inhibiting STAT1 activation [3]. IFNγ is 
also capable of activating MAPKs [4], another principal signaling pathway that includes 
JNK-1/2, p38 and ERK-1/2. MAPKs are activated by various extracellular stimuli such as 
oxidative stress, mitogens, hormones, growth factors, cytokines and chemokines [5]. As 
oxidative stress initiates APAP-hepatotoxicity [2], it is reasonable to speculate that 
MAPKs are involved in APAP-hepatotoxicity. In fact, mice injected with JNK inhibitor 
or lacking JNK (antisense treatment, siRNA, knock-out mice) were significantly 
protected against APAP-induced liver injury [6, 7], indicating a deleterious role of 
JNK-MAPK pathway. In contrast, p38-MAPK pathway does not appear to play a role [8]. 
ERK is also activated by APAP [7], but the contribution of ERK-MAPK pathway in 
APAP-hepatotoxicity remains unclear.   
Dysregulation of MAPKs may cause exacerbation of APAP-hepatotoxicity.  
Sprouty-related EVH1-domain-containing protein (Spred) is a family of proteins that 
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inhibit Ras-dependent ERK signaling. Spred-2 is ubiquitously expressed in various 
tissues including liver whereas Spred-1 and Spred-3 are preferentially expressed in the 
brain and cerebellum [9, 10]. However, the physiological functions of Spred proteins in 
the liver pathology remain largely unknown. In the present study, we have focused on 
Spred-2 and investigated the role in the evolution of APAP-induced liver injury. We 
demonstrate that Spred-2 knockout (KO) mice show enhanced APAP-hepatotoxicity. 
Our results suggest that the exacerbated liver injury in Spred-2 KO mice is due to the 
increased numbers of hepatotoxic lymphocytes such as CD4+T cells, CD8+T cells and 
NK cells, possibly by augmented CXCL9 and CXCL10 under the control of Kupffer 
cells and NK cells. 
 
2. Materials and Methods 
 
2.1. Mice 
Spred-2 KO mice backcrossed into the C57BL/6J background have been previously 
reported [11, 12]. C57BL/6J mice were used as the wild-type (WT) mice. These mice 
were transferred to the Department of Animal Resources, Okayama University (Okayama, 
Japan) and then bred at the facility. Female mice (6-8 weeks) were used in this study 
under specific pathogen-free conditions. The mice were housed in a 
temperature-controlled environment with a 12-hour light/12-hour dark cycle and allowed 
free access to water and food. The animal care and use committee at Okayama University 
approved all experiments conducted in this study. 
 
2.2. APAP-induced liver injury 
Fresh suspensions of APAP (Sigma Chemical Co., St. Louis, MO) were made 
immediately before use by dissolving the compound in phosphate-buffered saline (PBS) 
warmed to 40°C [3]. Mice were fasted for 12 h with free access to water and then 
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received intraperitoneal (i.p.) injection of APAP (400 mg/kg). At appropriate time 
intervals after APAP injection, mice were anesthetized, bled and sacrificed. Serum 
levels of alanine aminotransferase (ALT) were measured using standardized techniques. 
The livers were perfused with saline, excised, snap frozen in liquid nitrogen, and stored at 
-80°C for subsequent analyses. A part of the liver was fixed in 10% formalin, embedded 
in paraffin, and the liver sections were stained with hematoxylin and eosin. For some 
experiments, NK cells and Kupffer cells were deleted prior to APAP challenge. For NK 
cell-deletion, reconstituted anti-asialo GM1 antiserum (ASGM1; 20 µl/mouse, Wako 
Pure Chemical Industries, Osaka, Japan) was i.p. injected 12 h prior to APAP challenge 
[13]. Normal rabbit serum was used as a control. To delete Kupffer cells, mice were i.v. 
injected with 200 µl of clodronate encapsulated liposomes (Encapsula Nanosciences, 
Nashville, TN) 1 and 2 days before APAP-challenge. Empty liposomes were used as a 
control. All mice experiments were repeated two to three times and confirmed the 
reproducibility. 
 
2.3. Detection of apoptosis and caspase activity 
DNA fragmentation is a key feature of apoptosis. To detect DNA fragmentation in 
paraffin-embedded liver sections, ApopTag In Situ Detection Kit (Chemicon 
International, Inc., Temecula, CA) was used, according to manufacturers’ instructions. 
For the measurement of caspase-3, -8, -9 activities, colorimetric assay kit (MBL, Nagoya, 
Japan) for each caspase was used. The livers were homogenized in lysis buffer provided 
by the kit and the activities in the cytosolic extracts (100 µg protein) were measured with 
a kit. Protein concentrations in the extracts were measured by protein-dye binding assay 
(Bio-Rad Laboratories, Hercules, CA). 
 
2.4. Reverse transcription-PCR (RT-PCR) 
The tissues were homogenized in Trizol Reagent (Gibco BRL, Grand Island, NY), and 
 6 
total RNA was isolated. First-strand cDNA was constructed from 2 µg of total RNA with 
oligo (dT)12-18 as primers, and the cDNAs were used as a template for PCR. Quantitative 
real-time PCR for Fas and FasL was performed with a StepOne with Power SYBR PCR 
master mix (Applied Biosystems, Foster City, CA). The primers were as follows: Fas, 
sense: 5’-CTGCGATGAAGAGCATGGTTT-3’; anti-sense: 
5’-CCATAGGCGATTTCTGGGAC-3’. FasL, sense: 
5’-AAGAAGGACCACAACACAAATCTG-3’; anti-sense: 
5’-CCCTGTTAAATGGGCCACAC-3’. To validate the SYBR Green PCR products, a 
dissociation step was done to verify the Tm (annealing temperature) of the SYBR Green 
PCR product after the PCR were run. The expression levels of each mRNA were 
normalized by the expression of a housekeeping gene β-actin (sense: 
5’-GGTCATCACTATTGGCAACG-3’; anti-sense: 5’-ACGGATGTCAACGTCACACT-3’). 
mRNA expressions for IFNγ, CXCL9, CXCL10, CXCR3 and Spred-2 were measured 
by Taqman RT-PCR using GAPDH as the internal standard (Applied Biosystems). A 
standard Gel electrophoresis/RT-PCR was also carried out for Spred-2 and GAPDH. 
The primers were as follows: Spred-2, sense: 
5’-TGTGAGCACCGGAAGATTTATACC-3’; anti-sense: 
5’-CGCGGCGGCTTTGTGCTT-3’. GAPDH, sense: 
5’-TGTTCCAGTATGACTCCACTCACG-3’; anti-sense: 
5’-TCTGGGTGGCAGTGATGGCATGGA-3’. The PCR was carried out at 95°C 3 min, 
26 cycles of 95°C for 10 sec, 55°C for 10 sec, and 74°C for 1 min, and 74°C for 5 min. 
Ten microliters of PCR products were subjected to electrophoresis on a 2% agarose gel 
in presence of ethidium bromide, photographed and digitized.   
 
2.5. Isolation of hepatic leukocytes 
Hepatic leukocytes were isolated from the fresh liver [14]. In brief, mice were 
anesthetized and the livers were perfused in situ via the portal vein with 60 ml of HBSS at 
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a flow rate of 5 ml/min and then removed. The livers were minced and digested with 
0.02% (w/v) collagenase and 0.0005% (w/v) DNase I in HBSS containing 20 mM 
HEPES, pH 7.4, at 37 °C for 30 min with occasional shaking. The resulting cell 
suspension was filtered through a 75-μm nylon mesh and the filtrate was washed once 
with HBSS, layered over a 1.037 g/ml solution of Percoll (GE healthcare Bio-Sciences, 
Uppsala, Sweden) and centrifuged at 400 × g for 20 min. The resulting upper layer and 
interface, containing Ito cells, dead cells, and debris, were removed. The lower layer was 
diluted with Dulbecco’s PBS and centrifuged at 600 × g for 10 min to pellet the cells, 
re-suspended with PBS and the total cell numbers were counted by hemocytometer. 
 
2.6. Flow cytometry 
Hepatic leukocytes were suspended in PBS supplemented with 2% FCS and 0.1% sodium 
azaide, and stained with fluorescein isothiocyanate (FITC)-conjugated anti-CD3 
(145-2C11), phycoerythrin (PE)-conjugated anti-CD4 (GK1.5), FITC-conjugated 
anti-CD8 (53-6.7), FITC-conjugated anti-CD25 (3C7), PE-conjugated anti-NK1.1 
(PK136), FITC-conjugated Ly6G (RB6-8C5)(BD Pharmingen, San Jose, CA), 
PerCP/Cy5.5-conjugated CD11b (M1/70), PE-conjugated F4/80, FITC-conjugated IFNγ 
(BioLegend, San Diego, CA), PE-conjugated granzyme B and PE-conjugated perforin 
(eBioscience, San Diego, CA). The number of leukocyte populations in each liver was 
calculated by multiplying the respective percentages, as determined via flow cytometry, 
by total hepatic leukocyte counts. In case of intracellular staining for IFNγ, perforin and 
granzyme B, fixation/permealization and permealization buffers were used (eBioscience). 
The positive cell numbers was determined by gating on the respective cell types. Stained 
cells were analyzed using a Cell Lab Quanta SC MPL (Beckman Coulter, Inc., Brea, CA). 
 
2.7. Splenocytes culture 
Spleens were excised from WT and Spred-2 KO mice at 12 h after APAP treatment, and 
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the splenocytes were dispersed into single-cell suspensions. After lysing red blood cells, 
the cells (5 × 106 cells/ml) were suspended in RPMI 1640 supplemented with 5% FCS, 
glutamine and antibiotics and cultured for 72 h without stimulation. The culture 
supernatants were used for measurement of cytokines. 
 
2.8. Kupffer cell isolation and culture 
Non-parenchymal cells were isolated as described above. CD11b+ cells were isolated 
from the cells by anti-CD11b microbeads over MS+ MiniMACS separation columns 
(Miltenyi Biotec, Bergisch-Gladbach, Germany) according to instructions supplied by 
the manufacturer. Most of the purified cells were alive (>97%, trypan blue exclusion) and 
routinely >95% CD11b+ cells. The cells were plated onto 24 well at a density of 3 × 105 
cells per well, incubated for 1 h, non-adherent cells were washed off with RPMI1640 and 
fresh medium containing 10% FBS, glutamine and antibiotics was added. The adherent 
Kupffer cells were then stimulated with APAP (10 µg/ml) and IFNγ (10 ng/ml) for 4 h. 
RNA from each sample was purified using High Pure RNA Isolation Kit (Roche 
Diagnostics, Mannheim, Germany). 
 
2.9. Western blotting 
Cleared supernatants of liver homogenates were boiled with sample buffer that 
contained 1% SDS, 10 mmol/L Tris-HCl (pH 7.5), fractionated on SDS-polyacrylamide 
gel, and transferred to a nitrocellulose membrane. After blocking with TBS-T 
(Tris-buffered saline + 0.1% Tween-20) containing 5% skim milk for 1 h at room 
temperature, the membrane was incubated with antibodies to p44/42 MAPK (Erk1/2), 
phospho-p44/42 MAPK (Erk1/2), SAPK/JNK, phospho-SAPK/JNK, p38 MAPK, and 
phospho-p38 MAPK (Cell Signaling Inc, Beverly, MA) overnight at 4°C. After washing 
with TBS-T, the membrane was incubated with anti-HRP-linked antibody for 1 h at room 
temperature and visualized with an enhanced chemiluminescence system (Cell Signaling), 
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photographed and digitized.     
 
2.10. Measurement of cytokines 
Murine cytokines were measured using a standard method of sandwich ELISA, as 
described [15, 16]. The captured antibodies, detection antibodies and the recombinant 
cytokines were purchased from R&D Systems (Minneapolis, MN). The ELISAs 
employed in this study did not cross-react with other murine cytokines available. For 
cytokine measurement in the liver, livers were homogenized in PBS containing 0.1% 
TritonX-100 and complete protease inhibitor (Roche), centrifuged, and the cleared 
supernatants were obtained. 
 
2.11. Statistics 
Statistical significance was evaluated by ANOVA. A p < 0.05 was regarded as 
statistically significant.  All data were expressed as mean ± SEM. 
 
3. Results 
 
3.1. Expression and role of Spred-2 in APAP-induced liver injury 
To investigate the role of Spred-2, first experiments were conducted to examine the 
expression of endogenous Spred-2 in the liver. Consistent with previous reports [10, 17], 
Spred-2 was constitutively expressed in the liver. The expression level was increased 
and peaked at 3 h after APAP challenge (Fig. 1A), suggesting that endogenous Spred-2 
might be involved in APAP-induced liver injury.   
To understand the contribution of Spred-2 in APAP-hepatotoxicity, we 
employed Spred-2 KO mice. No appreciable level of Spred-2 was detected in Spred-2 
KO-liver (Fig. 1A inset). Taqman RT-PCR also showed no Spred-2 expression in 
Spred-2 KO-liver (data not shown). The data in Figure 1B demonstrated that ALT level, a 
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specific marker of liver injury, was significantly increased in Spred-2 KO mice as 
compared to WT controls. Histologically, centrilobular liver necrosis was much severer 
in Spred-2 KO mice than that in the WT mice (Fig. 1C and D). There was no significant 
difference in basal level of ALT between the groups (WT vs. Spred-2 KO, 64.9 ± 7.4 vs. 
65.7 ± 9.7 IU/L, not significant, 5 mice each). Basal glutathione levels in the liver were 
similar between the groups (WT vs. Spred-2 KO, 1.7 ± 0.1 vs. 1.9 ± 0.1 mM/g liver, not 
significant, 5 mice each). Thus, Spred-2 KO mice demonstrated exacerbated liver injury 
after APAP challenge. 
 
3.2. Hepatocyte apoptosis in Spred-2 KO mice 
In the mechanistic level, we first asked whether APAP-induced hepatocyte apoptosis 
would be augmented in Spred-2 KO mice. TUNEL staining of liver sections at 6 h 
post-APAP showed that apoptotic hepatocytes were increased in Spred-2 KO-liver, 
relative to the control (Fig. 2A and B). Caspases are a class of cysteine proteases involved 
in apoptosis. The data in Figure 2C demonstrated that activities of caspase-3, -8 and -9 in 
WT-liver were comparatively increased after APAP challenge, which were slightly 
augmented in Spred-2 KO-liver. Apoptosis is often initiated by death ligand/death 
receptor interactions, such as Fas ligand (FasL) with Fas, leading to a caspase activation 
cascade. mRNA expression of FasL, but not Fas, at 6 h post APAP was relatively 
increased in Spred-2 KO-liver compared to the controls (Fig. 2D). Thus, the increases in 
caspases/FasL in Spred-2 KO-liver were modest, suggesting that these pathways were 
unlikely the main cause of augmented liver injury in Spred-2 KO mice. 
 
3.3. Leukocyte populations in the liver after APAP challenge 
Liver histology in APAP-induced liver injury in humans shows hepatocyte damage with 
lymphocytic accumulation [18]. Experiments were conducted to examine the leukocyte 
populations in the liver. As shown in Figure 3A, the numbers of total leukocytes in the 
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liver were increased with time in WT mice, which was significantly augmented in 
Spred-2 KO mice. FACS analyses at 6 h post APAP challenge revealed that hepatotoxic 
lymphocytes that include CD4+T cells, CD8+T cells and NK cells (CD3-NK1.1+) were 
significantly increased in Spred-2 KO-liver as compared to the control (Fig. 3B). No 
difference was found in the numbers of NKT cells (CD3+NK1.1+), macrophages 
(CD11b+F4/80+), neutrophils (CD11b+Ly6G+) and regulatory T cells (CD4+CD25+) 
between WT- and Spred-2 KO-liver (WT vs. Spred-2 KO: 2.1 ± 0.2 vs. 2.4 ± 3.4, 0.5 ± 0.2 
vs. 5.9 ±0.2, 2.1 ± 0.6 vs. 2.8 ± 0.5, 0.4 ± 0.1 vs. 0.8 ± 0.2, × 105 cells/liver, not significant, 
14 mice each). There were no significant differences in the basal numbers of leukocyte 
populations between the groups (WT vs. Spred-2 KO: CD4+ T; 10.6 ± 1.4 vs. 11.1 ± 2.3, 
CD8+ T; 5.0 ± 0.9 vs. 4.9 ± 0.8, NK; 3.9 ± 0.9 vs. 3.9 ± 1.0, NKT; 12.5 ± 2.2 vs. 10.1 ± 2.2, 
macrophage; 4.5 ± 1.3 vs. 6.1 ± 1.3, neutrophils; 3.9 ± 0.4 vs. 2.8 ± 0.3, × 104 cells/liver, 
not significant, 4 mice each). Thus, APAP-induced leukocyte populations such as CD4+T 
cells, CD8+T cells and NK cells in the liver were augmented in Spred-2 KO mice. 
 
3.4. Increased IFNγ, CXCL9 and CXCL10 in Spred-2 KO mice 
APAP overdose results in elevated cytokines in the circulation. IFNγ is crucial in 
APAP-hepatotoxicity [19, 20], which stimulates the production of IFNγ-inducible 
chemokine CXCL9/CXCL10 that attracts and activates hepatotoxic lymphocytes such as 
CD4+T cells, CD8+T cells and NK cells [21]. We therefore investigated the cytokine 
response after APAP challenge. The data in Figure 4A showed that circulating levels of 
IFNγ, CXCL9 and CXCL10 were elevated in Spred-2 KO mice in comparison to those 
in WT mice. Hepatic levels of CXCL9, CXCL10 and their receptor CXCR3 were 
increased in Spred-2 KO mice (Fig. 4B). Basal levels of these cytokine/chemokines 
were negligible in WT and Spred-2 KO liver (data not shown). Although IFNγ level in 
whole livers were unchanged between the groups, the numbers of IFNγ positive-CD4+T 
cells, CD8+T cells and NK cells in Spred-2 KO mice were significantly augmented as 
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compared to the WT mice (Fig. 4C). The number of IFNγ positive cells in NKT cells 
remained unchanged between WT and Spred-2 KO mice (data not shown). Basal levels of 
IFNγ positive cells were very low and equivalent between the groups (WT vs. Spred-2 
KO: CD4+T; 0.22 ± 0.09 vs. 0.55 ± 0.42, CD8+T; 0.02 ± 0.02 vs. 0.05 ± 0.05, NK; 0.41 ± 
0.05 vs. 0.98 ± 0.57, NKT; 2.79 ± 0.89 vs. 1.12 ± 0.91, × 103 cells/liver, not significant, 3 
mice each). Given the early expression pattern of Spred-2 in the liver (Fig. 1A), Spred-2 
might alter cytokine response by affecting the other MAPK pathways. The data in Figure 
4D demonstrated that not only ERK- but also JNK- and p38-activation was enhanced in 
Spred-2 KO-liver relative to the control. Thus, deletion of Spred-2 demonstrated 
elevated hepatotoxic cytokine/chemokine response with boosted activation of multiple 
MAPK pathways. 
 
3.5. Cells responsible for enhanced IFNγ, CXCL9 and CXCL10 in Spred-2 KO 
mice 
Splenocytes harvested from either APAP-treated WT or Spred-2 KO mice did not 
spontaneously release appreciable levels of IFNγ, CXCL9 and CXCL10 (data not shown), 
suggesting that these cytokine/chemokines were produced not from circulating cells 
rather from cells in the liver. Kupffer cells are resident macrophage population in the 
liver with a potent capacity to produce multiple cytokines/chemokines [22], suggesting 
a possible source of hepatotoxic cytokine/chemokines in this model. To address this, 
Kupffer cells were isolated from WT and Spred-2 KO mice after APAP challenge and 
the expressions of these cytokine/chemokines were measured. As shown in Figure 5A, 
expressions of CXCL9 and CXCL10 in Kupffer cells were significantly elevated in 
Spred-2 KO mice as compared to those in WT mice. IFNγ was not detected in Kupffer 
cells from WT and Spred-2 KO mice (not shown). Accordingly, Kupffer cells were 
isolated from non-treated WT and Spred-2 KO mice and stimulated with APAP in vitro, 
which demonstrated that Kupffer cells from Spred-2 KO mice expressed significantly 
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higher levels of CXCL9 and CXCL10 than those from the WT mice (Fig. 5B). No IFNγ 
was detected from WT- and Spred-2 KO-Kupffer cells (data not shown). Upon 
stimulation with IFNγ, naïve Kupffer cells from Spred-2 KO mice also expressed higher 
levels of CXCL9 and CXCL10 in comparison to the controls (Fig. 5C) with no 
endogenous IFNγ (data not shown). The results suggest that Kupffer cells could be the 
source of the augmented CXCL9 and CXCL10 in Spred-2 KO mice. Together with data 
in Figure 4C, IFNγ appears to be derived from hepatotoxic lymphocytes.  
 
3.6. NK cells affect the augmented hepatotoxic T cell response in Spred-2 KO mice 
NK cells are known play a central role in APAP-hepatotoxicity by producing IFNγ [20]. 
To understand the role of NK cells in this model, we attempted to delete NK cells by 
anti-ASGM1 in Spred-2 KO mice. The data in Figure 6A showed that anti-ASGM1 
treatment significantly decreased IFNγ expression in the liver. Under the conditions, 
ALT level was decreased for up to 50% after the treatment with anti-ASGM1 (Fig. 6B). 
Histologically, centrilobular liver necrosis induced by APAP was dramatically improved 
by anti-ASGM1 as compared to the control (Fig. 6C). FACS analyses revealed that 
expression of perforin and granzyme B, injurious molecules produced from NK cells and 
CD8+ T cells, was reduced in Spred-2 KO-liver (Fig. 6D). 
 Leukocyte populations after anti-ASGM1 treatment were next examined. 
Anti-ASGM1 treatment resulted in an 87% reduction in the number of NK cells in the 
liver (Table 1). Subsequently, other leukocyte populations were also examined in the 
liver. Hepatic number of NKT cells was not affected by anti-ASGM1. Very interestingly, 
the numbers of CD4+T cells and CD8+T cells in the liver were considerably decreased 
after anti-ASGM1 treatment. Conversely, there was a trend toward increase in the 
number of CD4+FoxP3+T cells (p=0.14). The number of macrophages (CD11b+F4/80+ 
cells) was unchanged while that of neutrophils (CD11b+Ly6G+ cells) was decreased by 
50% although it was not statistically significant (Table 1). IFNγ positive cells in CD8+T 
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and NKT cells, but not CD4+T cell were decreased in mice treated with anti-ASGM1 (Fig. 
6E). Thus, depletion of NK cells attenuated APAP-hepatotoxicity in Spred-2 KO mice, 
an event that was associated with decreased numbers of CD4+T and CD8+T cells and 
decreased IFNγ positive cells in CD8+T cells and NKT cells. NK cells appear to be 
crucial in the subsequent recruitment of leukocytes and production of IFNγ from 
specific cell populations. 
 
4. Discussion 
Molecular interactions between toxicants and biological pathways are an emerging field of 
toxicology. Ras is a key-signaling molecule, and Spred proteins have a negative impact on 
Ras/Raf/ERK pathway by binding to Ras and consequently inhibiting phosphorylation of 
Raf [17]. In the present study, we have focused on Spred-2 in liver immunology and 
demonstrated for the first time that Spred-2 is protective in APAP-induced hepatotoxicity, 
as deletion of Spred-2 was vulnerable to the injury. 
 The exaggerated liver injury in Spred-2 KO mice appeared to be ascribed to the 
augmented numbers of hepatotoxic lymphocytes such as CD4+T cells, CD8+T cells and 
NK cells. IFNγ is crucial in the immune response during APAP-hepatotoxicity [19, 20]. 
Both CD4+ cells and CD8+T cells, known as type I effector T cells, are major sources of 
IFNγ. NK cells are deleterious in APAP-hepatotoxicity by producing IFNγ [20]. In this 
study, we showed that IFNγ-positive CD4+T cells, CD8+T cells and NK cells were 
increased in the liver from Spred-2 KO mice. In addition, IFNγ-inducible 
CXCL9/CXCL10 that attracts and activates these cell types was significantly augmented 
in the liver form Spred-2 KO mice. Increased CXCL9 and CXCL10 in Spred-2 KO mice 
appeared to result from the activation of Ras and p38. Activation of Ras promoted the 
overexpression of CXCL10 in human breast cancer cells primarily through the Raf and 
PI3K signaling pathways [23]. p38 participated in the regulation of CXCL9/CXCL10 
expression [4]. The numbers of NKT cells; also known to be deleterious in 
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APAP-hepatotoxicity were unchanged in our model, although the cells can be attracted 
by CXCL9 and CXCL10. This may be a result of activation-induced cell death or loss of 
surface marker expression of NKT cells [24, 25].  
 Very interestingly, reduction of NK cells with anti-ASGM1 significantly 
decreased APAP-induced liver injury with reduction in the hepatic numbers of not only 
NK cells but also CD4+T cells and CD8+T cells. Liver lymphocytes are abundant in NK 
cells (5-10%) and play an important role in first-line innate defense in the liver. NK cells 
directly and indirectly kill target cells by enhancing immune response through IFNγ 
production [26]. Decreased CD4+T cells and CD8+T cells by anti-ASGM1 may be its 
direct effect on these cells. It has demonstrated that ASGM1 is also expressed on certain 
CD4+T cells [27] and CD8+T cells [28]. Alternatively, NK cell deletion by anti-ASGM1 
may affect regulatory T cell differentiation. Activated NK cells interfere with 
CD28-mediated Foxp3 expression in CD4+CD25-T cells [29]. NK cells lyse 
CD4+CD25+Foxp3+T cells in certain conditions [30]. In the present study, NK cell 
depletion led to a trend toward increase in the number of regulatory T cells. The 
mechanism underlying the effects of anti-ASGM1 deserves attention. Employing 
anti-NK1.1 antibody or NKT-KO mice (CD1dKO mice) could be helpful to further 
understand the mechanism(s). 
 A previous study suggested that NK and NKT cells were not involved in 
APAP-hepatotoxicity [31]. Unlike in case of dimethylsulfoxide (DMSO) as a solvent, 
APAP failed to activate and recruit hepatic NK and NKT cells when dissolved in saline, 
suggesting that DMSO may play a role. However, in the present study, we clearly 
showed that APAP dissolved in PBS actually activated hepatic NK cells but not NKT 
cells as evidenced by increased NK cell numbers and higher intracellular levels of IFNγ, 
which was augmented in Spred-2 KO mice. We believe that NK cells play a role in 
APAP-hepatotoxicity under physiological conditions. 
Kupffer cells are located within the lumen of the liver sinusoids, and are the 
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first cell population encounters various stimuli including toxins, and release reactive 
oxygen species (ROS), cytokines and chemokines upon stimulation [22]. Our results 
suggest that Kupffer cells are responsible for the augmented CXCL9 and CXCL10 
response in Spred-2 KO mice. NK cells together with Kupffer cells are preferentially 
located in the hepatic sinusoids, often adhering to the endothelial cells [32]. NK cells may 
assist Kupffer cells to induce CXCL9 and CXC10 by releasing IFNγ.  
A question arises whether deletion of Kupffer cells could dampen the 
augmented liver injury in Spred-2 KO mice. The functional role of Kupffer cells in 
APAP-hepatotoxicity remains controversial. Previous studies showed that 
APAP-hepatotoxicity could be dramatically reduced by several Kupffer cell inactivators 
[33]; however, others showed an exacerbated APAP-liver injury in the absence of 
Kupffer cells [34, 35]. After Kupffer cell deletion with liposome/clodronate, we failed to 
reduce the augmented APAP-hepatotoxicity in Spred-2 KO mice. Serum ALT level was 
rather increased (liposome/control vs. liposome/clodronate, 5,152 ± 2,461 IU/L vs. 
10,200 ± 3,464 IU/L, p=0.35, 5 each), where liposome/clodronate decreased 70-80% of 
CD11b+F4/80+ cells at time 0 and 12 h after APAP challenge. Consistent with a previous 
report [35], Kupffer cell depletion by liposome/clodronate led to decreases in the hepatic 
level of hepato-regulatory cytokine IL-10 although it was not statistically significant 
(Relative expression: liposome/control vs. liposome/clodronate, 2.6 ± 1.7 vs. 0.06 ± 0.03, 
p=0.167, 5 each), suggesting that Kupffer cells or infiltrating macrophages are a 
significant source of IL-10. Recently, it has demonstrated that M2 macrophages that 
generate IL-10 are recruited into the liver after APAP challenge [36]. Mice deficient in 
CC chemokine receptor 2 (CCR2), the receptor for CCL2, showed reduced M2 
accumulation during APAP hepatotoxicity and consequently a substantial delay in tissue 
repair with increased neutrophil infiltration [36, 37]. These data suggest that 
liposome/clodronate also deletes M2 macrophage from the body, resulting in an 
enhanced APAP-induced liver injury via decreased IL-10. Thus, the controversy may 
 17 
stem from the heterogeneity and/or plasticity of macrophages and the difficulty in 
distinguishing and differentially studying subpopulations of macrophages in the liver. 
The other point needs to address in this study is the role of Spred-2 in 
parenchymal hepatocytes. Lacking Spred-2 in hepatocytes may directly affect 
APAP-hepatotoxicity. Hepatocytes are known to produce CXCL9 and CXCL10 [38]. 
However, using primary hepatocytes from WT and Spred-2 KO-liver, we did not find 
altered hepatocyte damage (LDH release from the cells) and CXCL9/CXCL10 
expression after stimulation with APAP and NAPQI (not shown). It remains 
undetermined whether inhibition of ERK or JNK in hepatocytes could inhibit lymphocyte 
infiltration and IFNγ/chemokine production in these mice. The function of Spred-2 in 
parenchymal hepatocytes needs to be further investigated.   
 APAP poisoning accounts for approximately one-half of all cases of acute liver 
failure in the United States and Great Britain. A better understanding of the signaling 
pathways involved in animal model may lead to novel insights and possible therapeutic 
targets.  In the present study, we have shown that lacking Spred-2 is deleterious in 
APAP-induced liver injury by enhancing hepatotoxic lymphocyte response, suggesting 
that Spred-2 may be a therapeutic target for the treatment of APAP-induced 
hepatotoxicity. 
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Figure legends  
 
Figure 1  APAP-induced liver injury. WT and Spred-2 KO mice were i.p. injected with 
APAP (400 mg/kg). (A) Spred-2 expression in the liver after APAP challenge was 
measured in WT mice (4-6 mice, each point). Inset; Spred-2 expression was not 
detected in Spred-2 KO-liver (representative data). †p<0.05, vs. non-treated mice. (B) 
Serum ALT levels were measured after APAP challenge (6-12 mice, each point). 
†p<0.05, vs. WT mice. (C) The representative photographs of the liver sections after 
APAP challenge were shown. Arrowheads indicate injured area (original magnification 
× 200). (D) Injured area was measured using H&E sections by NIH image (6-12 mice, 
each point). †p<0.05, vs. WT mice.  
 
Figure 2  Hepatocyte apoptosis in APAP-induced liver injury. WT and Spred-2 KO 
mice were i.p. injected with APAP (400 mg/kg). At 6 h after the injection, mice were 
killed. (A) Representative fluoromicroscopic photographs of liver sections with TUNEL 
staining were shown (original magnification × 200). (B) The numbers of 
TUNEL-positive hepatocytes/mm2 were counted in WT-liver (12 mice) and Spred-2 
KO-liver (15 mice). ‡p<0.01, vs. WT-liver. (C) Activities of caspase-3, -8 and -9 in 
WT-liver (10 mice) and Spred-2 KO-liver (12 mice). Dot lines were basal level of 
caspase activities from non-treated mice. †p<0.05 vs. WT mice. (D) The mRNA 
expressions of FasL and Fas in the WT-liver (10 mice) and Spred-2 KO-liver (12 mice) 
were analyzed by quantitative RT-PCR. The expression levels of each mRNA were 
normalized by β-actin. †p<0.05 vs. WT mice.   
 
Figure 3  Analysis of hepatic lymphocytes after APAP Challenge. At 6 h after APAP 
(400 mg/kg) challenge, hepatic leukocytes were isolated from WT and Spred-2 KO 
mice (10-14 mice, each point), and stained with FITC- or PE-conjugated mAbs and 
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analyzed by flow cytometry. (A) Total leukocyte numbers in the liver were shown. (B) 
Cell numbers in the liver in each population were shown. The number of leukocyte 
populations in each liver was calculated by multiplying the respective percentages, as 
determined via flow cytometry, by total hepatic leukocyte counts. Dot lines were basal 
level of cell numbers of each population from non-treated mice. ‡p<0.05, †p<0.01 vs. 
WT controls. 
 
Figure 4  Augmented cytokine response and MAPK activation in Spred-2 KO mice. 
At 6 h after APAP challenge (400 mg/kg), WT and Spred-2 KO mice (10 mice, each) 
were killed and the livers were harvested. (A) Serum levels of IFNγ, CXCL9 and 
CXCL10 were measured by ELISA. †p<0.01 vs. WT controls. (B) Hepatic mRNA 
expressions of CXCL9, CXCL10 and CXCR3 were quantitated by Taqman RT-PCR. 
The expression levels of each mRNA were normalized by GAPDH. ‡p<0.05 vs. WT 
controls. (C) Hepatic lymphocytes were stained with FITC- or PE-conjugated mAbs and 
analyzed by flow cytometry. ‡p<0.05, †p<0.01 vs. WT controls. (D) Livers were 
harvested at 6 h after APAP challenge and the extracts were immunoblotted with 
indicated antibodies. Shown are representative data from 2 mice each. 
 
Figure 5  Kupffer cells as a source of CXCL9 and CXCL10. (A) WT and Spred-2 KO 
mice were i.p. injected with APAP (400 mg.kg). At 4 h after the injection, mice were 
killed and the livers were harvested (5 each). Kupffer cells were isolated from the liver 
and mRNA expressions of CXCL9 and CXCL10 were quantitated by Taqman RT-PCR. 
The expression levels of each mRNA were normalized by GAPDH. Shown are 
representative data from 2 independent experiments. †p<0.01, ¶p<0.0001 vs. WT 
controls. (B and C) Kupffer cells were isolated from non-treated WT and Spred-2 
KO-liver (5 each) and stimulated with (B) APAP (10 µg/ml) and (C) IFNγ (10 ng/ml) for 
4 h at 37°C, after which the mRNA expressions of CXCL9 and CXCL10 in the cells 
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were quantitated by Taqman RT-PCR. The expression levels of each mRNA were 
normalized by GAPDH. Shown are representative data from 2 independent experiments. 
‡p<0.05, §p<0.001, ¶p<0.0001 vs. WT controls. 
 
Figure 6  NK cells play a crucial role in the exacerbated liver injury in Spred-2 KO 
mice. Spred-2 KO mice were pretreated with rabbit anti-asialo GM1 (ASGM1) serum 
(10 mice) or control rabbit serum (10 mice) (20 µl/mouse, i.p.) 12 h prior to APAP 
challenge, and the mice were i.p. injected with APAP (400 mg/kg). At 12 h after APAP 
challenge, the mice were killed and the livers were resected. (A) Hepatic IFNγ mRNA 
expression was quantitated by Taqman RT-PCR. The expression levels of each mRNA 
were normalized by GAPDH. (B) Serum levels of ALT were measured. (C) Left: The 
representative photographs of the liver sections. Arrowheads indicate injured area 
(original magnification × 200). Right: Injured area was measured using H&E sections by 
NIH image. (D) Hepatic lymphocytes were stained with FITC- or PE-conjugated mAbs 
and analyzed by flow cytometry. (E) Hepatic lymphocytes were stained with FITC- or 
PE-conjugated mAbs and analyzed by flow cytometry. The number of IFNγ positive 
cells in each liver was calculated by multiplying the respective percentages, as 
determined via flow cytometry, by total hepatic leukocyte counts. ‡p<0.05, †p<0.01 vs. 
WT controls. 
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Table 1  The numbers of leukocyte populations in the liver after ASGM1 treatment 
cell types control ( × 105 cells) ASGM1 ( × 105 cells) 
CD3-NK1.1+ 8.7 ± 1.4 1.1 ± 0.3 §  
CD3+NK1.1+  28.6 ± 4.4 34.0 ± 2.8 
CD4+CD8- 9.7 ± 2.0 5.2 ± 0.7 ‡ 
CD4-CD8+  11.2 ± 3.2 4.4 ± 0.6 ‡ 
CD4+FoxP3+ 1.8 ± 0.3 4.0 ± 1.5 
CD11b+F4/80+ 6.6 ± 2.3 8.1 ± 2.3  
CD11b+Ly6G+ 28.9 ± 11.1 14.7 ± 3.0 
Spred-2 KO mice were pretreated with rabbit anti-asialo GM1 serum (ASGM1: 10 
mice) or control rabbit serum (10 mice) 12 h prior to APAP challenge. Hepatic 
lymphocytes were harvested at 6 h after APAP challenge and stained with FITC- or 
PE-conjugated mAbs and analyzed by flow cytometry. ‡p<0.05, §p< 0.001, vs. WT 
controls.   
 
 
